ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Embecta Corporation

Embecta Corporation (EMBC)

13.81
0.20
( 1.47% )
Updated: 11:16:15

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
13.81
Bid
13.80
Ask
13.82
Volume
32,871
13.705 Day's Range 13.90
9.925 52 Week Range 19.79
Market Cap
Previous Close
13.61
Open
13.705
Last Trade
4
@
13.83
Last Trade Time
11:16:40
Financial Volume
$ 453,829
VWAP
13.8064
Average Volume (3m)
365,857
Shares Outstanding
57,701,830
Dividend Yield
4.34%
PE Ratio
11.29
Earnings Per Share (EPS)
1.22
Revenue
1.12B
Net Profit
70.4M

About Embecta Corporation

Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others. Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
Embecta Corporation is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker EMBC. The last closing price for Embecta was $13.61. Over the last year, Embecta shares have traded in a share price range of $ 9.925 to $ 19.79.

Embecta currently has 57,701,830 shares outstanding. The market capitalization of Embecta is $785.32 million. Embecta has a price to earnings ratio (PE ratio) of 11.29.

EMBC Latest News

UPDATE - embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results

PARSIPPANY, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference...

embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results

PARSIPPANY, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference...

embecta Celebrates National Diabetes Awareness Month by Ringing Nasdaq Closing Bell

PARSIPPANY, N.J., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company, announced it will ring the Nasdaq Closing Bell today in recognition...

embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes

While 9 out of 10 people with diabetes are living with T2D, many of the automated insulin delivery solutions currently on the market were designed for people living with T1D.300-unit insulin...

embecta to Participate in Investor Events

PARSIPPANY, N.J., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced that...

Embecta Corp. Reports Third Quarter Fiscal 2024 Financial Results

PARSIPPANY, N.J., Aug. 09, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three and...

embecta Announces Quarterly Cash Dividend

PARSIPPANY, N.J., Aug. 09, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.79-11.474358974415.615.6413.0538307514.03578033CS
4-0.24-1.7081850533814.0516.3713.0528314214.786241CS
12-1.66-10.730446024615.4717.0512.4236585714.83686824CS
26-0.12-0.86145010768113.9317.3311.4637303814.19032986CS
52-2.21-13.795255930116.0219.799.92541920914.69492516CS
156-18.55-57.323856613132.3636.649.92562300823.75183509CS
260-18.55-57.323856613132.3636.649.92562300823.75183509CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WORXSCWorx Corporation
$ 1.892
(93.06%)
105.42M
CRNCCerence Inc
$ 5.17
(83.33%)
32.73M
BDRXBiodexa Pharmaceuticals PLC
$ 6.13
(59.22%)
3.73M
IBGInnovation Beverage Group Limited
$ 1.1309
(42.93%)
6.83M
SPAISafe Pro Group Inc
$ 4.4871
(40.22%)
38.45M
PYXSPyxis Oncology Inc
$ 2.055
(-46.20%)
9.59M
GLXGGalaxy Payroll Group Ltd
$ 2.20
(-43.73%)
507.51k
KURAKura Oncology Inc
$ 9.99
(-37.21%)
7.54M
BLRXBioLineRx Ltd
$ 0.3571
(-34.50%)
5.72M
SHOTWSafety Shot Inc
$ 0.1001
(-33.27%)
2.5k
CDTConduit Pharmaceuticals Inc
$ 0.1109
(20.15%)
490.48M
NVDANVIDIA Corporation
$ 143.81
(-1.43%)
205.05M
AKTSAkoustis Technologies Inc
$ 0.1014
(16.42%)
183.54M
ELABElevai Labs Inc
$ 0.0201
(-6.07%)
150.44M
WORXSCWorx Corporation
$ 1.892
(93.06%)
105.42M

Your Recent History

Delayed Upgrade Clock